EditPep is a biotechnology business that creates a class of peptides capable of delivering CRISPR enzymes.
EditPep has raised $8.2M in total funding. The most recent round was Undisclosed. The last funding was announced in December 2024.
EditPep's investors include SkyDeck Berkeley.
EditPep is headquartered in Berkeley, United States.
EditPep is a biotechnology business that creates a class of peptides capable of delivering CRISPR enzymes.
EditPep is at the Undisclosed stage.
Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated .
"EditPep — Funding & Investors." VCBacked, December 19, 2024, https://www.vcbacked.co/company/editpep. Accessed August 14, 2026.
VCBacked. (2024). EditPep — Funding & Investors. Retrieved August 14, 2026, from https://www.vcbacked.co/company/editpep
{{cite web |title=EditPep — Funding & Investors |url=https://www.vcbacked.co/company/editpep |website=VCBacked |access-date=August 14, 2026}}Profile data sourced and verified per the VCbacked methodology · Last funding round dated